← All trials

NCT00220987

Phase 4Interventional

Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.

View on ClinicalTrials.gov ↗

Timeline

Start date
Apr 30, 2005
Primary completion
Nov 30, 2008
Completion date
Nov 30, 2008
First posted
Sep 22, 2005
Last posted
Jan 29, 2009
Enrollment
6104
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.